These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28320863)

  • 1. Rac1 GTPase regulates 11β hydroxysteroid dehydrogenase type 2 and fibrotic remodeling.
    Lavall D; Schuster P; Jacobs N; Kazakov A; Böhm M; Laufs U
    J Biol Chem; 2017 May; 292(18):7542-7553. PubMed ID: 28320863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.
    Lavall D; Selzer C; Schuster P; Lenski M; Adam O; Schäfers HJ; Böhm M; Laufs U
    J Biol Chem; 2014 Mar; 289(10):6656-6668. PubMed ID: 24469458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling.
    Lavall D; Jacobs N; Mahfoud F; Kolkhof P; Böhm M; Laufs U
    Biochem Pharmacol; 2019 Oct; 168():173-183. PubMed ID: 31283930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation.
    Adam O; Lavall D; Theobald K; Hohl M; Grube M; Ameling S; Sussman MA; Rosenkranz S; Kroemer HK; Schäfers HJ; Böhm M; Laufs U
    J Am Coll Cardiol; 2010 Feb; 55(5):469-80. PubMed ID: 20117462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation.
    Adam O; Theobald K; Lavall D; Grube M; Kroemer HK; Ameling S; Schäfers HJ; Böhm M; Laufs U
    J Mol Cell Cardiol; 2011 Apr; 50(4):678-85. PubMed ID: 21215756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice.
    Adam O; Zimmer C; Hanke N; Hartmann RW; Klemmer B; Böhm M; Laufs U
    J Mol Cell Cardiol; 2015 Aug; 85():140-50. PubMed ID: 26047574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha and phorbol 12-myristate-13-acetate down-regulate human 11beta-hydroxysteroid dehydrogenase type 2 through p50/p50 NF-kappaB homodimers and Egr-1.
    Kostadinova RM; Nawrocki AR; Frey FJ; Frey BM
    FASEB J; 2005 Apr; 19(6):650-2. PubMed ID: 15659537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2.
    Odermatt A; Arnold P; Frey FJ
    J Biol Chem; 2001 Jul; 276(30):28484-92. PubMed ID: 11350956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct fibrogenic effects of aldosterone on normotensive kidney: an effect modified by 11β-HSD activity.
    Brem AS; Morris DJ; Ge Y; Dworkin L; Tolbert E; Gong R
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1178-87. PubMed ID: 20200098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone enhances 11beta-hydroxysteroid dehydrogenase type 2 expression in colonic epithelial cells in vivo.
    Fukushima K; Funayama Y; Yonezawa H; Takahashi K; Haneda S; Suzuki T; Sasano H; Naito H; Shibata C; Krozowski ZS; Sasaki I
    Scand J Gastroenterol; 2005 Jul; 40(7):850-7. PubMed ID: 16109662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study.
    Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB
    Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11β-HSD2 SUMOylation Modulates Cortisol-Induced Mineralocorticoid Receptor Nuclear Translocation Independently of Effects on Transactivation.
    Jiménez-Canino R; Lorenzo-Díaz F; Odermatt A; Bailey MA; Livingstone DEW; Jaisser F; Farman N; Alvarez de la Rosa D
    Endocrinology; 2017 Nov; 158(11):4047-4063. PubMed ID: 28938454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone, estrogen, and the cyclic adenosine 5'-monophosphate pathway in cultured human placental and chorionic trophoblasts.
    Sun K; Yang K; Challis JR
    Biol Reprod; 1998 Jun; 58(6):1379-84. PubMed ID: 9623596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
    Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
    Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
    Quinkler M; Zehnder D; Lepenies J; Petrelli MD; Moore JS; Hughes SV; Cockwell P; Hewison M; Stewart PM
    Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia blocks 11beta-hydroxysteroid dehydrogenase type 2 induction in human trophoblast cells during differentiation by a time-dependent mechanism that involves both translation and transcription.
    Homan A; Guan H; Hardy DB; Gratton RJ; Yang K
    Placenta; 2006 Aug; 27(8):832-40. PubMed ID: 16271275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uninephrectomy reduces 11β-hydroxysteroid dehydrogenase type 1 and type 2 concomitantly with an increase in blood pressure in rats.
    Lauterburg M; Escher G; Dick B; Ackermann D; Frey FJ
    J Endocrinol; 2012 Sep; 214(3):373-80. PubMed ID: 22739210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rac1-Mediated Activation of Mineralocorticoid Receptor in Pressure Overload-Induced Cardiac Injury.
    Ayuzawa N; Nagase M; Ueda K; Nishimoto M; Kawarazaki W; Marumo T; Aiba A; Sakurai T; Shindo T; Fujita T
    Hypertension; 2016 Jan; 67(1):99-106. PubMed ID: 26527051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia causes down-regulation of 11 beta-hydroxysteroid dehydrogenase type 2 by induction of Egr-1.
    Heiniger CD; Kostadinova RM; Rochat MK; Serra A; Ferrari P; Dick B; Frey BM; Frey FJ
    FASEB J; 2003 May; 17(8):917-9. PubMed ID: 12626438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.